Mexico - Delayed Quote MXN

FUKUDA DENSHI CO (6960N.MX)

Compare
965.46
+10.45
+(1.09%)
At close: October 22 at 11:01:59 AM CST
Loading Chart for 6960N.MX
DELL
  • Previous Close 955.01
  • Open 0.00
  • Bid --
  • Ask --
  • Day's Range 1,032.13 - 1,032.13
  • 52 Week Range 1,032.13 - 1,032.13
  • Volume 0
  • Avg. Volume 4,500
  • Market Cap (intraday) --
  • Beta (5Y Monthly) 0.22
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Jan 31, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Fukuda Denshi Co., Ltd. engages in the manufacture and sale of medical instruments in Japan and internationally. It offers resting electrocardiograph and stress test products; patient monitoring systems, including central and bedside monitors, transmitters, and central viewer workstations; and vascular screening systems, such as data management software. Fukuda Denshi Co., Ltd. was founded in 1939 and is based in Tokyo, Japan.

fukuda.com

3,443

Full Time Employees

March 31

Fiscal Year Ends

--

Sector

--

Industry

Recent News: 6960N.MX

View More

Performance Overview: 6960N.MX

Trailing total returns as of 1/13/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

6960N.MX
0.00%
MSCI WORLD
1.17%

1-Year Return

6960N.MX
6.46%
MSCI WORLD
16.00%

3-Year Return

6960N.MX
6.46%
MSCI WORLD
14.35%

5-Year Return

6960N.MX
6.46%
MSCI WORLD
0.00%

Compare To: 6960N.MX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 6960N.MX

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    12.01%

  • Return on Assets (ttm)

    6.98%

  • Return on Equity (ttm)

    9.66%

  • Revenue (ttm)

    138.1B

  • Net Income Avi to Common (ttm)

    16.59B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    64.2B

  • Total Debt/Equity (mrq)

    1.05%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 6960N.MX

View More

Company Insights: 6960N.MX

Research Reports: 6960N.MX

View More